ROP
35
-3
ETR
55
3
AIZ
63
4
STI
7
-4
ICE
64
-3
DVN
43
-5
RRC
63
-2
AMAT
52
2
MTCH
50
-7
SPG
58
3
MS
74
-2
HSY
41
6
TSN
60
9
MSI
37
2
XRX
41
4
VRSK
28
5
SEE
53
-3
EMC
56
-4
MUR
38
-6
INTU
56
-9
ROP
35
-3
ETR
55
3
AIZ
63
4
STI
7
-4
ICE
64
-3
DVN
43
-5
RRC
63
-2
AMAT
52
2
MTCH
50
-7
SPG
58
3
MS
74
-2
HSY
41
6
TSN
60
9
MSI
37
2
XRX
41
4
VRSK
28
5
SEE
53
-3
EMC
56
-4
MUR
38
-6
INTU
56
-9
Financhill
Back

Compagnie de Saint-Gobain SA Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
60

CODYY
Compagnie de Saint-Gobain SA

Last Price:
$21.03
Seasonality Move:
4.91%
Sell
39

MNPR
Monopar Therapeutics, Inc.

Last Price:
$71.43
Seasonality Move:
36.18%
Buy
60
Compagnie de Saint-Gobain SA (CODYY) is a Buy

Is Compagnie de Saint-Gobain SA a Buy, Sell or Hold?

  • The current Compagnie de Saint-Gobain SA [CODYY] share price is $20.63. The Score for CODYY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • CODYY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $75.12. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CODYY Stock Price Chart

What is Compagnie de Saint-Gobain SA's stock price today?

  • The Compagnie de Saint-Gobain SA share price today is $20.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CODYY is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $75.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

CODYY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 60.19 Buy
Chaikin Money Flow: -32294 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.85 - 20.09) Buy
Bollinger Bands (100): (19.64 - 22.46) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.87 Sell
Relative Strength Index (14 RSI): 42.12 Sell
Chaikin Money Flow: -62944 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.34 - 86.56) Sell
Bollinger Bands (100): (44.09 - 88.71) Buy

CODYY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.02 Buy
20-day SMA: 19.55 Buy
50-day SMA: 19.9 Buy
200-day SMA: 21.49 Sell
8-day EMA: 20.1 Buy
20-day EMA: 19.81 Buy
50-day EMA: 20.06 Buy
200-day EMA: 20.64 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.09 Sell
20-day SMA: 81.11 Sell
50-day SMA: 83.94 Sell
200-day SMA: 51.58 Buy
8-day EMA: 77.09 Sell
20-day EMA: 79.63 Sell
50-day EMA: 78.25 Sell
200-day EMA: 56.2 Buy

Compagnie de Saint-Gobain SA Earnings Growth & CODYY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Compagnie de Saint-Gobain SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):